PREVALENCE AND MANAGEMENT OF URINARY TRACT INFECTIONS IN TYPE 2 DIABETIC PATIENTS

PDF

Published: 2022-12-29

DOI: 10.56557/upjoz/2022/v43i243335

Page: 375-386


NAJLAA MOHAMMAD ALSUDAIRY *

National Guard Hospital, King Abdulaziz Medical City, SCOHS, Jeddah, Saudi Arabia.

ELAF ABDULRAHEEM ABDULRAHMAN ALGHURAIBI

Baish General Hospital, Jazan, KSA.

KHOWLA MOHAMMED R. ALGETHAMI

King Saud Bin Abdul-Aziz University for Health Science, KSA.

ABDULRAHMAN AHMED M. ASIRI

GP, Mahyal Assir General Hospital, Mahyal Assir, Saudi Arabia.

ABDULLAH SULAIMAN ALQEFARI

Ministry of Health, KSA.

HASSAN SALEM HASSAN ALSHARYAH

Ministry of Health, KSA.

MOHAMMED AHMED HUMEYED

King Khaled University, KSA.

DINA GHURMULLAH M. ALZAHRANI

Hawtat Sudair General Hospital, KSA.

ZAINAB ABDULJALIL ALMANSUOR

King Faisal University, KSA.

AHMED SALMAN ALMEGDAD

MCH-DAMMAM, KSA.

ALMISBAH, MAHDI HASSAN A.

Prince Sultan Mulijah Hospital, KSA.

SHURUQ ABDULLAH S. ALBALAWI

MCH-Tabuk, KSA.

MUSTAFA YAHYA HUSSAIN NAJMI

Samtah General Hospital, KSA.

ABDULJALIL ALMARZOOQ

King Fahad Hospital Hufof-Alhasa, KSA.

KAWTHAR FAWAZ ALHAMWAN

Algharbei Primary Health Care Center, AlQurayyat, KSA.

*Author to whom correspondence should be addressed.


Abstract

Diabetes mellitus (DM) is a polygenic illness that affects many other organs. In people with type 2 diabetes, urinary tract infection is the most prevalent, the most severe, and has the worst consequences. They are also more frequently caused by microorganisms that are resistant to antibiotics. Immune system dysfunction, poor metabolic regulation, and inadequate bladder emptying owing to autonomic neuropathy may all contribute to these individuals' increased risk of urinary tract infections. The novel anti-diabetic sodium glucose cotransporter 2 inhibitors were not shown to raise the likelihood of symptomatic urinary tract infections appreciably. Urinary tract infection symptoms are comparable to those seen in people without diabetes, while some patients with diabetic neuropathy may exhibit changed clinical findings. The existence of symptoms, the severity of systemic symptoms, whether the infection is limited in the bladder or also includes the kidney, the presence of urologic abnormalities, concomitant metabolic disturbances, and renal function all influence treatment. There is no evidence that diabetic people with asymptomatic bacteriuria should be treated. Diabetes length, age, gender, method of drug administration, kind of medicines used in diabetes, poor glycemic control, obesity, unsanitary settings, sexual intercourse, and type of DM are all risk factors for UTI in diabetic patients. Antibiotic usage on a daily basis has rendered numerous harmful microorganisms resistant to their effects. In the long run, if UTI in diabetes people is not treated, it might lead to serious problems. Furthermore, the pattern of antibiotic resistance varies by geographical area. As a result, the use of susceptible antibiotics to treat UTI in diabetes patients has become critical. Medline and PubMed public database searches was carried out for papers written all over the world on UTI in diabetic patients. No predictive analytics technology was used. To evaluate the initial results and the methods of conducting the paper, the group members reviewed the data.

Keywords: Diabetes mellitus, urinary tract infection, antibiotics, management, prevalence, diabetic patients


How to Cite

ALSUDAIRY, N. M., ALGHURAIBI, E. A. A., ALGETHAMI, K. M. R., ASIRI, A. . A. M., ALQEFARI, A. S., ALSHARYAH, H. S. H., HUMEYED, M. A., ALZAHRANI, D. G. M., ALMANSUOR, Z. A., ALMEGDAD, A. S., A., A. M. H., ALBALAWI, S. A. S., NAJMI, M. Y. H., ALMARZOOQ, A., & ALHAMWAN, K. F. (2022). PREVALENCE AND MANAGEMENT OF URINARY TRACT INFECTIONS IN TYPE 2 DIABETIC PATIENTS. UTTAR PRADESH JOURNAL OF ZOOLOGY, 43(24), 375–386. https://doi.org/10.56557/upjoz/2022/v43i243335

Downloads

Download data is not yet available.

References

Hu FB. Globalisation of diabetes: the role of diet, lifestyle, and genes. Diabetes Care. 2011;34(6):1249–57.

De Fronzo RA. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med. 1999;131:281–303.

Patterson JE, Andriole VT. Bacterial urinary tract infections in diabetes. Infect Dis Clin North Am. 1997;11(3):735–50.

Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med. 1999; 341(25):1906–12.

Boyko EJ, Fihn SD, Scholes D, Abraham L, Monsey B. Risk of urinary tract infection and asymptomatic bacteriuria among diabetic and nondiabetic postmenopausal women. Am J Epidemiol. 2005;161(6):557–64.

Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care. 2003;26(2):510–3.

Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14:88–98.

NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387:1513–1530s.

Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care. 2003;26:510–3.

Fu AZ, Iglay K, Qiu Y, Engel S, Shankar R, Brodovicz K. Risk characterisation for urinary tract infections in subjects with newly diagnosed type 2 diabetes. J Diabetes Complicat. 2014;28(6):805–10.

Gupta K, Sahm DF, Mayfeld D, Stamm WE. Antimicrobial resistance among uropathogens that cause community acquired urinary tract infections in women: A nationwide analysis. Clin Infect Dis. 2001; 33(1):89–94.

Nitzan O, Elias M, Chazan B, Saliba W. Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management. Diabetes, metabolic syndrome and obesity: targets and therapy. 2015;8.:129–136.

Available:https://doi.org/10.2147/DMSO.S51792

Ellenberg M. Diabetic neuropathy: clinical aspects. Metabolism. 1976;25:1627–55.

Ellenberg M, Weber H. The incipient asymptomatic diabetic bladder. Diabetes. 1996;15:524–5.

Frimodt-Moller C. Diabetic cystopathy I–IV. Dan Med Bull. 1976;23:267–94.

Rodriguez-de-Velasquez A, Yoder IC, Velasquez PA, et al. Imaging the efects of diabetes in the genitourinary system. Radiographics. 1995;15:1051.

Wheat LJ. Infection and diabetes mellitus. Diabetes Care. 1980;3:187–97.

Sridhar CB, Anjana S, Mathew JT. Acute Infections. In: Ahuja MMS, Tripathy BB, Sam Moses GP, Chandalia HB, Das AK, Rao PV, editors. RSSDI Text Book of Diabetes Mellitus. Hyderabad, India. 2002;chap. 34:471–478.

Geerlings SE, Stolk RP, Camps MJ, et al. Asymptomatic bacteriuria can be considered a diabetic complication in women with diabetes mellitus. Adv Exp Med Biol. 2000;485: 309–14.

Fünfstück R, Nicolle LE, Hanefeld M, Naber KG. Urinary tract infection in patients with diabetes mellitus. Clin Nephrol. 2012; 77(1):40–8.

Truzzi JC, Almeida FM, Nunes EC, Sadi MV. Residual urinary volume and urinary tract infection—when are they linked? J Urol. 2008;180(1):182–5.

Hosking DJ, Bennett T, Hampton JR. Diabetic autonomic neuropathy. Diabetes. 1978;27(10): 1043–55.

Bonadio M, Costarelli S, Morelli G, Tartaglia T. The infuence of diabetes mellitus on the spectrum of uropathogens and the antimicrobial resistance in elderly adult patients with urinary tract infection. BMC Infect Dis. 2006;6:54.

Hooton TM, Scholes D, Hughes JP, Winter C, Roberts PL, Stapleton AE, et al. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med. (1996) 335:468–74.

DOI: 10.1056/NEJM199608153350703

Nichols GA, Brodovicz KG, Kimes TM, Déruaz-Luyet A, Bartels DB. Prevalence and incidence of urinary tract and genital infections among patients with and without type 2 diabetes. J Diabetes Complicat. 2017; 31(11):1587–91.

Hirji I, Guo Z, Andersson SW, Hammar N, Gomez-Caminero A. Incidence of urinary tract infection among patients with type 2 diabetes in the UK General Practice Research Database (GPRD). J Diabetes Complicat. 2012; 26(6):513–6.

de Lastours V, Foxman B. Urinary tract infection in diabetes: Epidemiologic considerations. Curr Infect Dis Rep. 2014; 16(1):389.

Schmiemann G, Kniehl E, Gebhardt K, et al. The diagnosis of urinary tract infection: A systematic review. Dtsch Arztebl Int. 2010; 107:361–7.

Carrondo MC, Moita JJ. Potentially preventable urinary tract infection in patients with type 2 diabetes— A hospital-based study. Obes Med. 2020;17:100190.

Hirji I, Guo Z, Andersson SW, Hammar N, Gomez-Caminero A. Incidence of urinary tract infection among patients with type 2 diabetes in the UK General Practice Research Database (GPRD). J Diabetes Complications. 2012; 26(6):513–516.

Hammar N, Farahmand B, Gran M, Joelson S, Andersson SW. Incidence of urinary tract infection in patients with type 2 diabetes. Experience from adverse event reporting in clinical trials. Pharmacoepidemiol Drug Saf. 2010;19(12):1287–1292.

Colgan R, Nicolle LE, McGlone A, Hooton TM. Asymptomatic bacteriuria in adults. Am Fam Physician. 2006;74(6):985–990.

Nicolle LE. Asymptomatic bacteriuria. Curr Opin Infect Dis. 2014; 27(1):90–96.

Zhanel GG, Nicolle LE, Harding GK. Prevalence of asymptomatic bacteriuria and associated host factors in women with diabetes mellitus. The Manitoba Diabetic Urinary Infection Study Group. Clin Infect Dis. 1995;21(2):316–322.

Schneeberger C, Kazemier BM, Geerlings SE. Asymptomatic bacteriuria and urinary tract infections in special patient groups: women with diabetes mellitus and pregnant women. Curr Opin Infect Dis. 2014;27(1):108–114.

Renko M, Tapanainen P, Tossavainen P, Pokka T, Uhari M. Metaanalysis of the significance of asymptomatic bacteriuria in diabetes. Diabetes Care. 2011;34(1):230–235.

Aswani SM, Chandrashekar U, Shivashankara K, Pruthvi B. Clinical profile of urinary tract infections in diabetics and non-diabetics. Australas Med J. 2014;7(1):29–34.

Scholes D, Hooton TM, Roberts PL, Gupta K, Stapleton AE, Stamm WE. Risk factors associated with acute pyelonephritis in healthy women. Ann Intern Med. 2005;142(1): 20–27.

Nicolle LE, Friesen D, Harding GK, Roos LL. Hospitalization for acute pyelonephritis in Manitoba, Canada, during the period from 1989 to 1992; impact of diabetes, pregnancy, and aboriginal origin. Clin Infect Dis. 1996;22(6):1051–1056.

Benfield T, Jensen JS, Nordestgaard BG. Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome. Diabetologia. 2007;50(3):549–554.

Bilo HJ. Susceptibility to infection in patients with diabetes mellitus. Ned Tijdschr Geneeskd. Dutch. 2006;150(10):533–534.

Wen SC, Juan YS, Wang CJ, et al. Emphysematous prostatic abscess: Case series study and review. Int J Infect Dis. 2012; 16(5):e344–e349.

Chen SL, Jackson SL, Boyko EJ. Diabetes mellitus and urinary tract infection: epidemiology, pathogenesis and proposed studies in animal models. J Urol. 2009;182(6 Suppl):S51–S56.

Wang MC, Tseng CC, Wu AB, et al. Bacterial characteristics and glycemic control in diabetic patients with Escherichia coli urinary tract infection. J Microbiol Immunol Infect. 2013;46(1):24–29.

Boyko EJ, Fihn SD, Scholes D, Chen CL, Normand EH, Yarbro P. Diabetes and the risk of acute urinary tract infection among postmenopausal women. Diabetes Care. 2002;25(10):1778–1783.

Soo Park B, Lee SJ, Wha Kim Y, Sik Huh J, Il Kim J, Chang SG. Outcome of nephrectomy and kidney-preserving procedures for the treatment of emphysematous pyelonephritis. Scand J Urol Nephrol. 2006;40(4):332–338.

Geerlings SE, Brouwer EC, Van Kessel KC, Gaastra W, Stolk RP, Hoepelman AI. Cytokine secretion is impaired in women with diabetes mellitus. Eur J Clin Invest. 2000;30(11): 995–1001.

Kaplan SA, Te AE, Blaivas JG. Urodynamic findings in patients with diabetic cystopathy. J Urol. 1995;153(2):342–344.

Frimodt-Møller C. Diabetic cystopathy: epidemiology and related disorders. Ann Intern Med. 1980;92(2 Pt 2):318–321.

Al-Rubeaan KA, Moharram O, Al-Naqeb D, Hassan A, Rafiullah MR. Prevalence of urinary tract infection and risk factors among Saudi patients with diabetes. World J Urol. 2013; 31(3):573–578.

Nicolle LE, Capuano G, Fung A, Usiskin K. Urinary tract infection in randomized phase III studies of canagliflozin, a sodium glucose co-transporter 2 inhibitor. Postgrad Med. 2014; 126(1): 7–17.

Yang XP, Lai D, Zhong XY, Shen HP, Huang YL. Efficacy and safety of canagliflozin in subjects with type 2 diabetes: systematic review and meta-analysis. Eur J Clin Pharmacol. 2014;70(10):1149–1158.

Ptaszynska A, Johnsson KM, Parikh SJ, de Bruin TW, Apanovitch AM, List JF. Safety profile of dapagliflozin for type 2 diabetes: pooled analysis of clinical studies for overall safety and rare events. Drug Saf. 2014; 37(10):815–829.

Geerlings SE, Meiland R, van Lith EC, Brouwer EC, Gaastra W, Hoepelman AI. Adherence of type 1-fimbriated Escherichia coli to uroepithelial cells: more in diabetic women than in control subjects. Diabetes Care. 2002;25(8):1405–1409.

Colodner R, Rock W, Chazan B, et al. Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis. 2004;23(3):163–167.

Wu YH, Chen PL, Hung YP, Ko WC. Risk factors and clinical impact of levofloxacin or cefazolin nonsusceptibility or ESBL production among uropathogens in adults with community-onset urinary tract infections. J Microbiol Immunol Infect. 2014;47(3): 197–203.

Schechner V, Kotlovsky T, Kazma M, et al. Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected? Clin Microbiol Infect. 2013;19(5):451–456.

Papadimitriou-Olivgeris M, Drougka E, Fligou F, et al. Risk factors for enterococcal infection and colonization by vancomycin-resistant enterococci in critically ill patients. Infection. 2014;42(6):1013–1022.

Sobel JD, Fisher JF, Kauffman CA, Newman CA. Candida urinary tract infections – epidemiology. Clin Infect Dis. 2011;52(Suppl 6): S433–S436

Sibi G, Devi AP, Fouzia K, Patil BR. Prevalence, microbiologic profile of urinary tract infection and its treatment with trimethoprim in diabetic patients. Res J Microbiol. 2011;6:543-51.

Yismaw G, Asrat D, Woldeamanuel Y, Unakal CG. Urinary tract infection: Bacterial etiologies, drug resistance profile and associated risk factors in diabetic patients attending Gondar University Hospital, Gondar, Ethiopia. Eur J Exp Biol. 2012;2:889-98.

Gutema T, Weldegebreal F, Marami D, Teklemariam Z. Prevalence, antimicrobial susceptibility pattern, and associated factors of urinary tract infections among adult diabetic patients at Metu Karl Heinz Referral Hospital, Southwest Ethiopia. Int J Microbiol. 2018;2018:1-7.

Tandogdu Z, Wagenlehner FM. Global epidemiology of urinary tract infections. Curr Opin Infect Dis. 2016;29:73-9.

Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009:32(7): 1335–43.

Kim Y, Wie SH, Chang UI, et al. Comparison of the clinical characteristics of diabetic and non-diabetic women with community-acquired acute pyelonephritis: a multicenter study. J Infect. 2014;69(3):244–251.

Stamm WE. Measurement of pyuria and its relation to bacteriuria. Am J Med. 1983; 75(1B):53–58.

Giesen LG, Cousins G, Dimitrov BD, van de Laar FA, Fahey T. Predicting acute uncomplicated urinary tract infection in women: a systematic review of the diagnostic accuracy of symptoms and signs. BMC Fam Pract. 2010;11:78.

Hooton TM, Bradley SF, Cardenas DD, et al. Infectious Diseases Society of America Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults. Clin Infect Dis. 2010;50(5):625–663.

Kass EH. Asymptomatic infections of the urinary tract. Trans Assoc Am Physicians. 1956;69:56–64.

Rubin RH, Shapiro ED, Andriole VT, Davis RJ, Stamm WE. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis. 1992;15 Suppl 1:S216–S227

Stark RP, Maki DG. Bacteriuria in the catheterized patient. What quantitative level of bacteriuria is relevant? N Engl J Med. 1984;311(9): 560–564.

Raz R. Asymptomatic bacteriuria. Clinical significance and management. Int J Antimicrob Agents. 2003;22 Suppl 2:45–47.

Zhanel GG, Harding GK, Nicolle LE. Asymptomatic bacteriuria in patients with diabetes mellitus. Rev Infect Dis. 1991;13(1): 150–154.

Dielubanza EJ, Mazur DJ, Schaeffer AJ. Management of non-catheter-associated complicated urinary tract infection. Infect Dis Clin North Am. 2014;28(1):121–134.

Nicolle LE, Zhanel GG, Harding GK. Microbiological outcomes in women with diabetes and untreated asymptomatic bacteriuria. World J Urol. 2006;24(1):61–65.

Nicolle LE. Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis. UrolClin North Am. 2008; 35(1):1–12.

Park B, Lee SJ, Kim Y, Huh J, Kim J, Chang G. Outcome of nephrectomy and kidney-preserving procedures for the treatment of emphysematous pyelonephritis. Scand J Urol Nephrol. 2006;40(4):332–338.

Thomas AA, Lane BR, Thomas AZ, Remer EM, Campbell SC, Shoskes DA. Emphysematous cystitis: a review of 135 cases. BJU Int. 2007;100(1):17–20.

Lin WR, Chen M, Hsu JM, Wang CH. Emphysematous pyelonephritis: patient characteristics and management approach. Urol Int. 2014;93(1):29–33.

Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM, Infectious Diseases Society of America, American Society of ephrology, American Geriatric Society. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis. 2005;40(5):643–654.

Batalla MA, Balodimos MC, Bradley RF. Bacteriuria in diabetes mellitus. Diabetologia. 1971;7(5):297–301.

Meiland R, Geerlings SE, Stolk RP, Netten PM, Schneeberger PM, Hoepelman AI. Asymptomatic bacteriuria in women with diabetes mellitus: effect on renal function after 6 years of follow-up. Arch Intern Med. 2006; 166(20):2222–2227.

Nicolle LE, Zhanel GG, Harding GK. Microbiological outcomes in women with diabetes and untreated asymptomatic bacteriuria. World J Urol. 2006;24(1):61– 65.

Harding GK, Zhanel GG, Nicolle LE, Cheang M. Manitoba Diabetes Urinary Tract Infection Study Group. Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. N Engl J Med. 2002;347(20):1576–1583.

Gupta K, Hooton TM, Naber KG, et al. Infectious Diseases Society of America; European Society for Microbiology and Infectious Diseases. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52(5): e103–e120.

Geerlings SE. Urinary tract infections in patients with diabetes mellitus: Epidemiology, pathogenesis and treatment. Int J Antimicrob Agents. 2008;31 Suppl 1:S54-7.

Lin WR, Chen M, Hsu JM, Wang CH. Emphysematous pyelonephritis: Patient characteristics and management approach. Urol Int. 2014;93(1):29–33.

Chan JC, Cockram CS, Critchley JA. Drug-induced disorders of glucose metabolism. Mechanisms and management. Drug Saf. 1996; 15(2):135–157.

Munar MY, Singh H. Drug dosing adjustments in patients with chronic kidney disease. Am Fam Physician. 2007;75(10):1487–1496.